Exposure to SARS-CoV-2 and Infantile Diseases

Area of Science:

• Immunology
• Pediatrics
• Molecular Mimicry

Background:

• Investigating immune responses to SARS-CoV-2 in children is crucial.
• Understanding potential cross-reactivity between SARS-CoV-2 and human proteins is a key research area.

Purpose of the Study:

• To analyze the potential for anti-SARS-CoV-2 immune responses to target human proteins involved in infantile diseases via molecular mimicry.
• To explore the role of shared immune determinants and immunologic imprinting.

Main Methods:

• Comparative sequence analysis to identify shared minimal immune pentapeptide determinants between SARS-CoV-2 spike glycoprotein and human proteins linked to infantile disorders.
• Assessment of the immunologic potential and imprinting phenomena of shared peptides.

Main Results:

• Identified 54 shared pentapeptides between SARS-CoV-2 spike glycoprotein and human proteins associated with infantile diseases.
• Confirmed immunologic potential of shared peptides, present in validated SARS-CoV-2 epitopes.
• Found shared peptides in common infectious pathogens, suggesting feasibility of immunologic imprinting.

Conclusions:

• Molecular mimicry and cross-reactivity may link SARS-CoV-2 exposure to pediatric diseases.
• Immunologic memory and a child's infection history are critical in shaping immune responses and autoimmune sequelae.